Skip to main content
Year archive

ANGLE PLC — 2025 filings

All 38 regulatory filings released by ANGLE PLC (AGL) in 2025, sourced directly from the official regulator.

38 Filings
2025 Period
2025 filings (38)
Filing Released Lang
Holding(s) in Company
Major Shareholding Notification
2025-12-23 English
PDMR Dealing and ESOT Share Purchase
Director's Dealing
2025-12-19 English
Results of General Meeting and Board Changes
Regulatory Filings
2025-12-15 English
Additional Subscription
Share Issue/Capital Change
2025-12-02 English
Result of Retail Offer
Share Issue/Capital Change
2025-12-01 English
Update to Admission of Fundraising Shares
Share Issue/Capital Change
2025-11-25 English
Launch of Retail Offer
Share Issue/Capital Change
2025-11-25 English
Result of Oversubscribed Placing and Subscription
Share Issue/Capital Change
2025-11-25 English
Proposed Placing and Subscription
Capital/Financing Update
2025-11-24 English
QIAGEN Collaboration and Co-Marketing Agreement
Regulatory Filings
2025-11-18 English
Further Update on Funding
Capital/Financing Update
2025-11-05 English
CelLBxHealth Presents Proof-of-Concept Study
Regulatory Filings
2025-11-05 English
Expert Consensus on CTCs; Update on Funding
Regulatory Filings
2025-11-04 English
CHANGE OF NAME
Regulatory Filings
2025-10-29 English
Appointments: Interim CEO and senior board advisor
Board/Management Information
2025-10-16 English
Strategy Update
Regulatory Filings
2025-10-08 English
Presentation of Data on Glioblastoma
Regulatory Filings
2025-09-29 English
Board Changes
Board/Management Information
2025-09-12 English
Interim Results
Interim / Quarterly Report H1 2025
2025-09-09 English
Change of Adviser
Board/Management Information
2025-09-09 English
Notice of Results
Report Publication Announcement
2025-09-05 English
ANGLE announces collaboration with Myriad Genetics
Regulatory Filings
2025-08-20 English
PARSORTIX ENABLES STUDY OF CANCER PROGRESSION
Regulatory Filings
2025-07-08 English
Result of 2025 Annual General Meeting
AGM Information
2025-06-30 English
EACR 2025: Innovation in AR expression profiling
Regulatory Filings
2025-06-17 English
EACR 2025: Data demonstrating DNA dual analysis
Regulatory Filings
2025-06-17 English
Novel discoveries into the biology of cancer
Regulatory Filings
2025-06-10 English
POSTING OF ANNUAL REPORT AND NOTICE OF AGM
Report Publication Announcement
2025-06-09 English
Board Changes
Board/Management Information
2025-06-06 English
Preliminary Results
Interim / Quarterly Report FY 2024
2025-05-28 English
Notice of Results
Report Publication Announcement
2025-05-23 English
RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
Regulatory Filings
2025-04-28 English
Issue of LTIP Options and Share Options
Regulatory Filings
2025-03-21 English
Results of Eisai Phase 2 pilot study
Regulatory Filings
2025-03-21 English
Novel findings using Parsortix
Regulatory Filings
2025-02-06 English
Analysis of CTC-DNA and ctDNA using Illumina assay
Regulatory Filings
2025-01-29 English
Parsortix used in research paper from ETH Zurich
Environmental & Social Information
2025-01-24 English
Trading Update
Earnings Release FY 2024
2025-01-23 English